USP10 and chronic myelogenous leukemia, BCR-ABL1 positive: Further investigations show that USP10 as a novel deubiquitinase of SKP2 amplifies the activation of Bcr-Abl via mediating deubiquitination and stabilization of SKP2 in CML cells.